Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Multiple Myeloma- Vitamin D3 as Therapy
“…the present study highlights a widespread and alarming rate of vitamin D deficiency in patients with metastatic bone disease and multiple myeloma…”
According to the study linked and excerpted below, blood levels of vitamin D3 are an important predictor of multiple myeloma.
I began supplementing with Vitamin D3
- I firmly believe that supplementing with Vitamin D3
- Vitamin D3 is a well-researched nutritional supplement –
- Vitamin D3 aids in my side-effect management including nerve-damage, chemobrain, chemo-induced heart damage and others-
According to ConsumerLabs.com optimal blood levels of Vitamin D3
LEF Vitamin D3
- Vitamin D3
- LEF Vitamin D3
- Cost-effective at .01 cents cost per 400 IU (.01 cents to .06 cost per 400 IU in ConsumeLab.com evaluation range)
- LEF Vitamin D3
- 5% of your Amazon purchase will be donated to PeopleBeatingCancer to support cancer patients with research and education-
Thank you
David Emerson
- Long-term MM Survivor,
- MM Cancer Coach
- Director PeopleBeatingCancer
Recommended Reading:
- Vitamin D3, Chronic Disease and Cancer
- Healing Spine Fractures in Multiple Myeloma
- Multiple Myeloma- The Cure vs. Control Debate
“Conclusion: Vitamin D levels are frequently low among multiple myeloma patients and, despite this, screening levels of this vitamin is not thought to be part of the routine work up by the vast majority of oncologists in the United States.”
Vitamin D Deficiencies Can Impact Myeloma Outcomes
“Most people do not think about their vitamin D intake, but Chloe Spear, BSN, RN, OCN, knows that it is important – especially for patients with myeloma.
Spear, clinical specialty coordinator in the Myeloma Program at Mount Sinai, conducted a study examining the effects that a vitamin D deficiency can have on outcomes for patients with myeloma. She hopes to turn her findings – that patients with deficiencies have poorer prognoses – into a standard-of-care for treating patients who come into the clinic with vitamin D deficiencies. Intervention would be fairly simple and straightforward: prescribing patients with oral vitamin D supplements to take daily.”
Prevalence of Vitamin D Deficiency in Patients with Bone Metastases and Multiple Myeloma
“We found a widespread and alarming rate of vitamin D deficiency in patients with metastatic bone disease and multiple myeloma. Of note, patients with bone metastases due to breast cancer, prostate cancer and multiple myeloma rarely reached sufficient serum 25-OH-D levels.
Conclusion: It is of utmost clinical importance to assess vitamin D levels in cancer patients, especially in those with, or at high risk of developing metastatic bone disease…
In summary, the present study highlights a widespread and alarming rate of vitamin D deficiency in patients with metastatic bone disease and multiple myeloma.
Of note, patients with bone metastases due to breast cancer, prostate cancer and multiple myeloma rarely reached sufficient serum 25-OH-D levels and yet vitamin D deficiency often goes unrecognised and therefore remains untreated. Hence, it is of utmost clinical importance to assess vitamin D levels in cancer patients, especially those with, or at high risk of developing metastatic bone disease.
